Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NEUROShield

K-Number: K220034 · 2023-09-14

Decision Date2023-09-14
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

NEUROShield is a medical device manufactured by In-Med Prognostics L3c. It received FDA 510(k) clearance on 2023-09-14 under approval number K220034. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NEUROShield?

NEUROShield is a medical device that received FDA 510(k) clearance on 2023-09-14. It is manufactured by In-Med Prognostics L3c. The 510(k) number is K220034.

When was NEUROShield approved by the FDA?

NEUROShield received FDA 510(k) clearance on 2023-09-14, under approval number K220034.

What company makes NEUROShield?

NEUROShield is manufactured by In-Med Prognostics L3c.

What is the FDA product code for NEUROShield?

The FDA product code for NEUROShield is LLZ.

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.